FindTrial
Sign In

The effect of Frailty Score on predicting perioperative complications of liver cirrhotic patients undergoing endoscopic treatment

The effect of Frailty Score on predicting perioperative complications of liver cirrhotic patients undergoing endoscopic treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033246
Enrollment
Unknown
Registered
2020-05-25
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

Gold Standard:Clinical outcomes
Index test:Preoperative&#32
assessment&#32
of&#32
frailty

Sponsors

The First Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ASA I-III level, cirrhotic patients who underwent endoscopic treatment with anesthesia inpatient

Exclusion criteria

Exclusion criteria: We excluded patients who were with gastrointestinal hemorrhage in acute stage, with severe anemia (hemoglobin less than 70g /L), with known or predicted difficult airway, with moderate or severe heart and lung function impairment, with asthma, or with hepatic encephalopathy.

Design outcomes

Primary

MeasureTime frame
Complications;SEN, SPE, ACC;—

Countries

China

Contacts

Public ContactXiangming Fang

The First Affiliated Hospital, School of Medicine, Zhejiang UniversityFirst Affiliated Hospital, School of Medicine, Zhejiang University

0099418@zju.edu.cn+86 13857161019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026